Reinsurance and So Much More

---

Cutting edge biologics and pharmaceuticals are designed to help patients with rare and complex diseases. Clinically appropriate management to ensure the right product for the right patient is incredibly important, and RareRe manages that process.

Products for Rare diseases come with exorbitant costs because of their limited use and expensive research and manufacturing to bring them to patients.  Cost management is important for the future of the program, and RareRe  manages Value Based Purchasing (VBP) with best in class metrics and additional cost mitigation strategies.

Working with patients, manufacturers and payors, RareRe collects critical data that can satisfy:

• Phase IV commitments
• REMS requirements
• IND investigations of new disease applications
• VBP arrangements, and 
• clinically appropriate patient management.